JW Jungwoo Pharmaceutical Reports Operating Loss of 4.5 Billion KRW in Q2... Returns to Deficit
[Asia Economy Reporter Minji Lee] JW Pharmaceutical announced on the 31st that it recorded an operating loss of 4.48 billion KRW in the second quarter, turning to a deficit. Sales amounted to 135.953 billion KRW, an increase of 1.35% compared to the same period last year. The net loss for the period was 7.3 billion KRW, also turning to a deficit.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Controversy Over Mysterious Numbers at Starbucks: From Sewol Ferry and Park Geun-hye to May 18
- Cost Instability Grips 'AI Rally'... Iran War Identified as the Cause
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
